Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,431.20
1.20 (0.08%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹19.50K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
30.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,200+19.3%
52W High₹1,885-24.1%
Current Price
₹1,431.20
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,144.96
Upper Circuit₹1,717.44
Reference Price
₹1,431.20
Investment Checklist
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹1612.0
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1531.0
Composite score 40.67 (BUY) with 84.4% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
84%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
1424.77
EMA50
1403.83
EMA200
1479.95
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows6
Lower Highs3
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹1475.02
₹1522.26
₹1564.50
₹1606.30
₹1634.50
Support (Below)
₹1418.83
₹1391.70
₹1357.00
₹1337.60
₹1319.10
Volume Analysis
TrendINCREASING
Change+13.80%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹1416.89
3% Risk₹1388.26
5% Risk₹1359.64
7% Risk (Custom)
₹1331.02Technical Levels
1x ATR (Volatility)₹1390.91
2x ATR (Swing)₹1350.62
3x ATR (Trend)₹1310.33
Immediate Support₹1418.83
Moving Averages
EMA 20 (Medium-term)₹1424.77
EMA 50 (Trend)₹1403.83
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹702.6 Cr | ₹771.6 Cr | ₹790.2 Cr | ₹800.9 Cr |
| Net Profit | ₹93.5 Cr | ₹118 Cr | ₹120.2 Cr | ₹99.7 Cr |
| EPS | — | ₹8.66 | ₹8.82 | ₹7.32 |
| Operating Profit | ₹260.4 Cr | ₹280.3 Cr | ₹291.3 Cr | ₹264.5 Cr |
ROE
12.33%
ROCE
13.51%
Debt/Equity
0.87
Current Ratio
0.89
OPM
33.03%
NPM
12.45%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Eris Lifesciences Limited | ₹1,431.20 | +0.08% | 30.6 | ₹19.50K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Interim Dividend - Rs 7.21 Per Share | INTERIM_DIVIDEND |
| 13 Feb 2025 | Interim Dividend - Rs 7.35 Per Share | INTERIM_DIVIDEND |
| 17 Sept 2024 | Annual General Meeting | AGM |
| 15 Sept 2023 | Annual General Meeting | AGM |
| 23 Aug 2022 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ERIS
View All
positive
ET Markets - Stocks 37d ago
Ipca Laboratories among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish momentum as their RSI crossed above 50, signaling potential upward price movement.
BANKINDIAEMULTIMQERISINDIANBIOBIPCALABMANKINDMOMENTUMSOUTHBANKTHELEELAConsumer ServicesFinancial Services
NEWS
neutral
Business Standard - Markets 50d ago
Epack Durable Ltd leads losers in 'A' group
Jubilant Foodworks Ltd, P I Industries Ltd, JK Lakshmi Cement Ltd and ERIS Lifesciences Ltd are among the other losers in the BSE's 'A' group today, 21 May 2026.
BSEEPACKERISJKCEMENTJKLAKSHMIJUBLFOODConstruction MaterialsConsumer Durables
positive
ET Markets - Stocks 51d ago
Eris Lifesciences among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks featured in the RSI Trending Up scan on May 20 after gaining over 5%. The RSI moved above the 50 mark from lower levels, signalling improving momentum, strengthening price action, and potential short-term buying opportunities for traders tracking bullish technical setups and momentum-based market trends.
AONETMMQ50EMULTIMQERISMOMENTUMFinancial ServicesHealthcare